Plasma homocyst(e)ine levels in men with premature coronary artery disease

U.S. Department of Agriculture, Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111.

Plasma homocyst(e)ine (that is, the sum of free and bound homocysteine and its oxidized forms, homocystine and homocysteine-cysteine mixed disulfide) levels were determined in 170 men (mean age +/- SD 50 +/- 7 years) with premature coronary artery disease diagnosed at coronary angiography and in 255 control subjects clinically free of coronary artery disease (mean age 49 +/- 6 years). Patients with coronary artery disease had a higher homocyst(e)ine level than control subjects (13.66 +/- 6.44 versus 10.93 +/- 4.92 nmol/ml, p less than 0.001). High density lipoprotein (HDL) cholesterol levels were lower (32 +/- 10 versus 46 +/- 13 mg/dl, p less than 0.001) and triglycerides levels were higher (193 +/- 103 versus 136 +/- 106 mg/dl, p less than 0.001) in the coronary disease group. Plasma total cholesterol and low density lipoprotein (LDL) cholesterol levels were not significantly different between patients with coronary disease and control subjects. The presence of hypertension, smoking or diabetes mellitus did not significantly alter homocyst(e)ine levels in the patient or the control group. Patients who were not taking a beta-adrenergic blocking drug (n = 70) had a nonsignificantly higher homocyst(e)ine level than did patients taking this class of drugs (n = 100) (14.67 +/- 8.92 versus 12.95 +/- 3.77 nmol/ml, p = 0.087). By design, none of the control subjects were taking a beta-blocker. No significant correlations were observed between homocyst(e)ine and age, serum cholesterol, LDL cholesterol, HDL cholesterol or triglyceride levels. It is concluded that an elevated plasma homocyst(e)ine level is an independent risk factor for the development of premature coronary atherosclerosis in men.

This article has been cited by other articles:

				H. Refsum, E. Nurk, A. D. Smith, P. M. Ueland, C. G. Gjesdal, I. Bjelland, A. Tverdal, G. S. Tell, O. Nygard, and S. E. Vollset The Hordaland Homocysteine Study: A Community-Based Study of Homocysteine, Its Determinants, and Associations with Disease J. Nutr., June 1, 2006; 136(6): 1731S - 1740S. [Abstract] [Full Text] [PDF]

				Homocysteine Studies Collaboration Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis JAMA, October 23, 2002; 288(16): 2015 - 2022. [Abstract] [Full Text] [PDF]

				J. A. Tice, E. Ross, P. G. Coxson, I. Rosenberg, M. C. Weinstein, M. G. M. Hunink, P. A. Goldman, L. Williams, and L. Goldman Cost-effectiveness of Vitamin Therapy to Lower Plasma Homocysteine Levels for the Prevention of Coronary Heart Disease: Effect of Grain Fortification and Beyond JAMA, August 22, 2001; 286(8): 936 - 943. [Abstract] [Full Text] [PDF]

				T. Kosokabe, K. Okumura, T. Sone, J. Kondo, H. Tsuboi, H. Mukawa, T. Tomida, T. Suzuki, H. Kamiya, H. Matsui, et al. Relation of a Common Methylenetetrahydrofolate Reductase Mutation and Plasma Homocysteine With Intimal Hyperplasia After Coronary Stenting Circulation, April 24, 2001; 103(16): 2048 - 2054. [Abstract] [Full Text] [PDF]

				Y. Jang, J. H. Lee, E. Y. Cho, N. S. Chung, D. Topham, and B. Balderston Differences in body fat distribution and antioxidant status in Korean men with cardiovascular disease with or without diabetes Am. J. Clinical Nutrition, January 1, 2001; 73(1): 68 - 74. [Abstract] [Full Text] [PDF]

				V. Shpichinetsky, I. Raz, Y. Friedlander, N. Goldschmidt, I. D. Wexler, A. Ben-Yehuda, and G. Friedman The Association between Two Common Mutations C677T and A1298C in Human Methylenetetrahydrofolate Reductase Gene and the Risk for Diabetic Nephropathy in Type II Diabetic Patients J. Nutr., October 1, 2000; 130(10): 2493 - 2497. [Abstract] [Full Text]

				G. E. Cooke, G. M. Eaton, G. Whitby, R. A. Kennedy, P. F. Binkley, M. L. Moeschberger, and C. V. Leier Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients J. Am. Coll. Cardiol., August 1, 2000; 36(2): 509 - 516. [Abstract] [Full Text] [PDF]

				M. R. Malinow, P. B. Duell, A. Irvin-Jones, B. M. Upson, and E. E. Graf Increased Plasma Homocyst(e)ine after Withdrawal of Ready-to-Eat Breakfast Cereal from the Diet: Prevention by Breakfast Cereal Providing 200 {micro}g Folic Acid J. Am. Coll. Nutr., August 1, 2000; 19(4): 452 - 457. [Abstract] [Full Text] [PDF]

				G. L. Booth, E. E.L. Wang, and with the Canadian Task Force on Preventive Health Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events Can. Med. Assoc. J., July 1, 2000; 163(1): 21 - 29. [Abstract] [Full Text] [PDF]

				W. G. Christen, U. A. Ajani, R. J. Glynn, and C. H. Hennekens Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual? Arch Intern Med, February 28, 2000; 160(4): 422 - 434. [Abstract] [Full Text] [PDF]

				H. H. Yu, R. Joubran, M. Asmi, T. Law, A. Spencer, M. Jouma, and N. Rifai Agreement among Four Homocysteine Assays and Results in Patients with Coronary Atherosclerosis and Controls Clin. Chem., February 1, 2000; 46(2): 258 - 264. [Abstract] [Full Text] [PDF]

				S. K. Osganian, M. J. Stampfer, D. Spiegelman, E. Rimm, J. A. Cutler, H. A. Feldman, D. H. Montgomery, L. S. Webber, L. A. Lytle, L. Bausserman, et al. Distribution of and Factors Associated With Serum Homocysteine Levels in Children: Child and Adolescent Trial for Cardiovascular Health JAMA, April 7, 1999; 281(13): 1189 - 1196. [Abstract] [Full Text] [PDF]

				M. R. Malinow, A. G. Bostom, and R. M. Krauss Homocyst(e)ine, Diet, and Cardiovascular Diseases : A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association Circulation, January 12, 1999; 99(1): 178 - 182. [Full Text] [PDF]

				W. H. Giles, J. B. Croft, K. J. Greenlund, E. S. Ford, and S. J. Kittner Total Homocyst(e)ine Concentration and the Likelihood of Nonfatal Stroke : Results From the Third National Health and Nutrition Examination Survey, 1988–1994 Stroke, December 1, 1998; 29(12): 2473 - 2477. [Abstract] [Full Text] [PDF]

				S. M. Grundy, G. J. Balady, M. H. Criqui, G. Fletcher, P. Greenland, L. F. Hiratzka, N. Houston-Miller, P. Kris-Etherton, H. M. Krumholz, J. LaRosa, et al. Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction Circulation, May 19, 1998; 97(18): 1876 - 1887. [Full Text] [PDF]

				N. J. Wald, H. C. Watt, M. R. Law, D. G. Weir, J. McPartlin, and J. M. Scott Homocysteine and Ischemic Heart Disease: Results of a Prospective Study With Implications Regarding Prevention Arch Intern Med, April 27, 1998; 158(8): 862 - 867. [Abstract] [Full Text] [PDF]

				E. K. Hoogeveen, P. J. Kostense, P. J. Beks, A. J. C. Mackaay, C. Jakobs, L. M. Bouter, R. J. Heine, and C. D. A. Stehouwer Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes Mellitus : A Population-Based Study Arterioscler. Thromb. Vasc. Biol., January 1, 1998; 18(1): 133 - 138. [Abstract] [Full Text] [PDF]

				K. Kottke-Marchant, R. Green, D. W. Jacobsen, A. Gupta, S. R. Savon, M. Secic, and K. Robinson High Plasma Homocysteine: A Risk Factor for Arterial and Venous Thrombosis in Patients with Normal Coagulation Profiles Clinical and Applied Thrombosis/Hemostasis, October 1, 1997; 3(4): 239 - 244. [Abstract] [PDF]

				R. W. Evans, B. J. Shaten, J. D. Hempel, J. A. Cutler, and L. H. Kuller Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1947 - 1953. [Abstract] [Full Text]

				A. D'Angelo and J. Selhub Homocysteine and Thrombotic Disease Blood, July 1, 1997; 90(1): 1 - 11. [Full Text] [PDF]

				B. Christensen, P. Frosst, S. Lussier-Cacan, J. Selhub, P. Goyette, D. S. Rosenblatt, J. Genest Jr, and R. Rozen Correlation of a Common Mutation in the Methylenetetrahydrofolate Reductase Gene With Plasma Homocysteine in Patients With Premature Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., March 1, 1997; 17(3): 569 - 573. [Abstract] [Full Text]

				K. Robinson, A. Gupta, V. Dennis, K. Arheart, D. Chaudhary, R. Green, P. Vigo, E. L. Mayer, J. Selhub, M. Kutner, et al. Hyperhomocysteinemia Confers an Independent Increased Risk of Atherosclerosis in End-Stage Renal Disease and Is Closely Linked to Plasma Folate and Pyridoxine Concentrations Circulation, December 1, 1996; 94(11): 2743 - 2748. [Abstract] [Full Text]

				J. Ma, M. J. Stampfer, C. H. Hennekens, P. Frosst, J. Selhub, J. Horsford, M. R. Malinow, W. C. Willett, and R. Rozen Methylenetetrahydrofolate Reductase Polymorphism, Plasma Folate, Homocysteine, and Risk of Myocardial Infarction in US Physicians Circulation, November 15, 1996; 94(10): 2410 - 2416. [Abstract] [Full Text]

				P. M. Gallagher, R. Meleady, D. C. Shields, K. S. Tan, D. McMaster, R. Rozen, A. Evans, I. M. Graham, and A. S. Whitehead Homocysteine and Risk of Premature Coronary Heart Disease: Evidence for a Common Gene Mutation Circulation, November 1, 1996; 94(9): 2154 - 2158. [Abstract] [Full Text]

				D. E.L. Wilcken, X. L. Wang, A. S. Sim, and R. M. McCredie Distribution in Healthy and Coronary Populations of the Methylenetetrahydrofolate Reductase (MTHFR) C677T Mutation Arterioscler. Thromb. Vasc. Biol., July 1, 1996; 16(7): 878 - 882. [Abstract] [Full Text]

				F. M.T. Loehrer, C. P. Angst, W. E. Haefeli, P. P. Jordan, R. Ritz, and B. Fowler Low Whole-Blood S-Adenosylmethionine and Correlation Between 5-Methyltetrahydrofolate and Homocysteine in Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., June 1, 1996; 16(6): 727 - 733. [Abstract] [Full Text]

				I. Fermo, S. V. D'Angelo, R. Paroni, G. Mazzola, G. Calori, and A. D'Angelo Prevalence of Moderate Hyperhomocysteinemia in Patients with Early-Onset Venous and Arterial Occlusive Disease Ann Intern Med, November 15, 1995; 123(10): 747 - 753. [Abstract] [Full Text]

				K. Robinson, E. L. Mayer, D. P. Miller, R. Green, F. van Lente, A. Gupta, K. Kottke-Marchant, S. R. Savon, J. Selhub, S. E. Nissen, et al. Hyperhomocysteinemia and Low Pyridoxal Phosphate : Common and Independent Reversible Risk Factors for Coronary Artery Disease Circulation, November 15, 1995; 92(10): 2825 - 2830. [Abstract] [Full Text]

				P. N. Hopkins, L. L. Wu, J. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1314 - 1320. [Abstract] [Full Text]